BioengineeringAdvanced SciencePeer-reviewed
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
Bhawana Pandey, Zhengying Wang, Angela C. Jimenez…·Krishnendu Roy
This study develops a mucosal nanovaccine that enhances both systemic and lung-specific immunity against SARS-CoV-2 in mice through intranasal and intramuscular delivery.
6 citations